New pre-print claiming extraordinary benefit from low dose rapamycin (6mg/week) with improvements in #PEM recovery/lessened OI/lessened fatigue. Measured over 3 months. n=86. No controls. Reliable sampling (Bateman) pubmed.ncbi.nlm.nih.gov/40502741/
Low Dose Rapamycin Alleviates Clinical Symptoms of Fatigue and PEM in ME/CFS Patients via Improvement of Autophagy - PubMedLow-dose rapamycin effectively reduced PEM and other key symptoms in patients with ME/CFS, as measured by BAS, SSS, MFI, and SF-36. Future studies should encompass dose optimization and develop a diag...pubmed.ncbi.nlm.nih.gov